Search Results

0 results for 'Kelley Drye & Warren LLP'

You can use to get even better search results
July 01, 2009 |

Arbitration Scorecard: Treaties

A listing of investment treaty arbitrations active in 2007-2008 in which at least $100 million was in controversy. Expanded for the Web.
71 minute read
May 01, 2012 |

Big Deals

Cisco/NDS; Pentali/Tyco Flow Control; Zayo/AboveNet
7 minute read
Securities and Exchange Commission v. Raj Rajaratnam, 10-462-cv
Publication Date: 2010-09-30
Practice Area: Business Law
Industry:
Court: U.S. Court of Appeals, Second Circuit
Judge: Before: Raggi, Lynch, and Chin, C.JJ
Attorneys:
For plaintiff: Kevin P. McGrath, Senior Trial Counsel, Securities and Exchange Commission, New York, New York (Valerie A. Szczepanik, Senior Trial Counsel, Securities and Exchange Commission, New York, New York; David M. Becker, General Counsel, Mark D. Cahn, Deputy General Counsel, Jacob H. Stillman, Solicitor, Mark Pennington, Assistant General Counsel, David Lisitza, Senior Counsel, Securities and Exchange Commission, Washington, DC, on the brief), for Plaintiff-Appellee. Reed M. Brodsky, (Andrew L. Fish, on the brief), Assistant United States Attorneys for Preet Bharara, United States Attorney for the Southern District of New York, New York, New York, for Amicus Curiae United States of America in support of Plaintiff-Appellee.
For defendant: Patricia A. Millett, Akin Gump Strauss Hauer & Feld LLP, Washington, DC (Robert H. Hotz, Jr., Samidh Guha, Akin Gump Strauss Hauer & Feld LLP, New York, New York; John M. Dowd, Terence J. Lynam, William E. White, Kevin R. Amer, Issaac J. Lidsky, Anne J. Lee, Akin Gump Strauss Hauer & Feld LLP, Washington, DC, Alan R. Kaufman, James M. Keneally, Thomas B. Kinzler, Kelley Drye & Warren LLP, New York, New York, on the brief), for Defendants-Appellants. Craig Green, Associate Professor, Temple Law School, Philadelphia, Pennsylvania, Douglas R. Jensen, Park & Jensen LLP, New York, New York, for Amici Curiae John Does Number One, Two and Three. Marc Rotenberg, (John Verdi, Jared Kaprove, on the brief), Electronic Privacy Information Center, Washington, DC, for Amicus Curiae Electronic Privacy Information Center (EPIC) in support of Defendants-Appellants.
Case number:

Cite as: Securities and Exchange Commission v. Raj Rajaratnam, 10-462-cv, NYLJ 1202472687879, at *1 (2d Cir., Decided September 29, 2010)Before: Raggi, Lynch,

February 28, 2008 |

In re �Agent Orange� Product Liability Litigation

Agent Orange Claims by Vietnam War Veterans Barred By Military Contractor Defense; Dismissal Upheld
60 minute read
April 27, 2000 |

Names Behind the News

Who's coming and going at firms across the country.
4 minute read
May 08, 2002 |

New Deals

In a deal valued at about million, Seattle-based biopharmaceutical company Immunex Corp., announced last week that it had agreed to sell its Leukine cancer treatment business to Berlin`s Schering AG, a global research-based company engaged in the discovery, development, manufacture, marketing and sale of pharmaceutical products. Immunex was required by the Federal Trade Commission to sell the cancer treatment business after it agreed to a friendly takeover by Thousand Oaks, Calif.-based biotechnology Amgen
3 minute read
April 14, 2004 |

Bano v. Union Carbide Corp.

Issue Exists as to When Plaintiff Learned of Alleged Damage to Property Following Released Chemicals
41 minute read
Banks Lose Rehearing Bid in Lawyer's Airport Bond Crusade
Publication Date: 2013-08-07
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

The case of Linda Grant Williams—the former Big Law partner who picked a fight with Wall Street titans—has been bouncing around the courts for five years. Fortunately for Williams, this week a New York appellate court refused to give the litigation another bounce in the banks' favor.

April 17, 2002 |

Securities Regulation

T here is widespread agreement that radical reform of the Securities Act of 1933 (Securities Act) is necessary and, indeed, long overdue. A law review article advocating the abolition of the integration doctrine asserts that "the doctrine does not promote investor protection but does retard capital formation" and "furthers no valid purpose" of the Securities Act. 1 Similar statements could be made with respect to the "gun-jumping" doctrine and other bans on general solicitation. The integrated disclosure in
10 minute read
November 12, 2007 |

The 2007 NLJ 250

6 minute read

TRENDING STORIES

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now